General Information of DTT (ID: TTNIZ2B)

DTT Name PCSK9 messenger RNA (PCSK9 mRNA) DTT Info
Gene Name PCSK9

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Preclinical Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Inclisiran DMP3YTE Familial hypercholesterolemia 5C80.00 Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AZD8233 DMBT2D2 Cardiovascular disease BA00-BE2Z Phase 2 [2]
MPSK3169A DMMRYEK Cardiovascular disease BA00-BE2Z Phase 2 [3]
------------------------------------------------------------------------------------
2 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ALN-PCS DMCJMOS Hypercholesterolaemia 5C80.0 Preclinical [4]
BMS-PCSK9 DMRCMEK Coronary artery disease BA80 Preclinical [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 FDA Approved Drug Products from FDA Official Website. 2021. Application Number: 214012.
2 AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval. Br J Clin Pharmacol. 2022 Nov;88(11):4839-4844.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2388).
4 Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc (2011).
5 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).